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oleellisesti AMI-potilaan leikkausviiveeseen ja kuolleisuuteen. Hoitoketjun 
sujuvoittaminen niin, että potilas pääsee mahdollisimman nopeasti hoitoon vatsaelin- 
ja verisuonikirurgiseen yksikköön, voi parantaa AMI:n hoidon tuloksia. 
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Abstract 
 
 
Objectives: Despite modern advances in diagnosis and treatment, arterial acute mesenteric 
ischaemia (AMI) remains a disease of high mortality. One of the key modifiable factors in AMI is 
the first-door-to-operation delay, but the factors attributing to this delay are largely unknown. The 
aim of this study was to evaluate the factors affecting delay, with special focus on the pathways to 
treatment. 
Design: This was a single academic centre retrospective study.  
Materials and methods: Patients undergoing intervention due to AMI caused by thrombosis or 
embolism of superior mesenteric artery between 2006 and 2015 were identified from electronic 
patient records. Patients not eligible for intervention or with chronic, subacute onset, colonic only, 
venous, or non-occlusive mesenteric ischaemia were excluded. Patients were divided to two groups 
according to the first speciality examining the patient (surgical emergency room (SER), surgeon 
examining the patient first or non-surgical emergency room (non-SER), internist examining the 
patient first). The primary endpoint was first-door-to-operation delay and secondary endpoints were 
length of stay and 90-day mortality. 
Results: Eighty-one patients with AMI were included. Fifty patients (62%) died during the first 30 
days and 53 (65%) within 90 days. Presenting first in non-SER (vs. SER) was independently 
associated with a first-door-to-operation delay of over 12 hours (OR 3.7 (95% confidence interval 
1.3-10.2), median delay 15.2 hours (IQR 10.9-21.2) vs. 10.1 hours (IQR 6.9-18.5), respectively, p  
= 0.025). The length of stay was shorter (median 6.5 days (4.0-10.3) vs. 10.8 days (7.0-22.3), p  = 
0.045) and 90-day mortality was lower in the SER group (50.0% vs. 74.5%, p  = 0.025).  
Conclusions: First specialty that the patient encounters seem to be crucial for both delay and early 
survival of AMI. Developing fast/direct pathways to a gastro-vascular unit offers a possibility to 
improve outcomes of AMI.  
Keywords: embolus, thrombosis, delay, emergency, revascularization 
  
 1 
Introduction 
 
Acute mesenteric ischaemia (AMI) is a relatively uncommon abdominal emergency, accounting for 
about 1:1000 of acute hospital admissions in Europe and the USA, yet incidence increases 
dramatically with age.1-4 AMI has historically been a disease in which diagnosis is difficult, if not 
impossible, treatment nearly futile, and mortality very high.5-7  Patients present with a wide variety 
of symptoms and only about 1% of acute abdomen cases are caused by AMI, which makes it 
difficult to guide all patients immediately to the correct unit.4 Computed tomography (CT)  is today 
widely available in emergency rooms (ER) facilitating identification of anatomy consistent with a 
diagnosis of AMI.8 Treatment of AMI has evolved from mere removal of necrotic material to 
revascularisation of the remaining bowel.4,92 Mini-invasive revascularisation methods have 
emerged due to the technological development of endovascular treatment options.4,10,112 
Introduction of intestine stroke units with multimodal treatment options have improved both bowel 
and life outcomes.12,13 Despite better results in selected revascularisation series, the total AMI 
mortality has remained very high, usually cited at 42–69 %.4 In addition to the fact that AMI itself 
is highly deadly, patients presenting with AMI are usually elderly with several comorbidities.4 
Much of the effort in the development of treatment strategies for AMI has recently focused on new 
endovascular treatments. Delays and pathways to treatment have gained much less attention, even 
though long delays are known to be a major contributing factor for outcome. Patients are often 
referred to a vascular centre too late, at the time of irreversible ischaemia. Potential reasons for long 
delays are a low level of suspicion, difficulties in diagnostics and operation room logistics.14,15 The 
sensitivity of CT to identify the occlusion of superior mesenteric artery (SMA) in the initial 
radiologists report varies between 66-86%, and is significantly improved if suspicion of AMI is 
raised in the referral.16  
Although delay is a key modifiable factor in the treatment of AMI, few studies have sought 
addressable targets to reduce it.   
 2 
The aim of this study was to analyse the delays in the treatment of AMI and to seek out the factors 
related to this process. Identifying the key steps in the care pathway may lead to shorter delays and 
ultimately better patient outcomes. Specifically, the role of the first ER where the patient presented 
was examined. 
 
Materials and methods 
This retrospective cohort study was performed in an academic teaching hospital (Helsinki 
University Hospital) that functions as a tertiary and secondary referral centre covering a population 
of approximately 1.5 million. Helsinki University Hospital is the only hospital within the area that 
treats vascular emergencies, and thus all patients with AMI within the catchment area are instructed 
to be referred there. Open, endovascular, and hybrid revascularisation options are available at all 
times. Patients who were treated for AMI in Helsinki University Hospital in 2006-2015 were 
identified from electronic patient records by conducting a search for the International Classification 
of Diseases 10 (ICD-10) code K55 (Vascular disorders of intestine) or Nomesco Classification of 
Surgical Procedures (NCSP) codes for procedures on mesenteric vessels (PCE17, PCF16, PCF17, 
PCHXX, PCJ17, PCN16, PCN17, PCP16, PCP17, PCQ16, PCQ17, PCQ99). Appropriate permits 
to conduct the study were obtained from the institutional review board.   
 
Definitions  
Patients were classified based on the first ER and specialty where they presented. Generally, in 
Nordic countries, there are two types of ERs – surgical ERs have surgeons (or surgical residents) in 
the ER seeing the patient first. Non-surgical ERs have internists (or more recently emergency 
medicine doctors) seeing the patient first but may consult surgeon in deemed necessary. 
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In this study, surgical emergency room (SER) was defined as any ER (secondary or tertiary) where 
the patient was seen first by a surgeon (or surgical resident). Non-surgical emergency room (non-
SER) was defined as an ER where the patient was first seen by either primary care doctor, internal 
medicine doctor or an emergency medicine physician. The training and experience of the staff in 
SER and non-SER is similar (both residents and attendings of respective specialities). SER and non-
SER are located in the same premises in some of the hospitals, while in others they are located in 
different buildings.  
 
In most hospitals, both primary care ER and secondary care ERs (either internal medicine or 
surgical ER, or both) work at the same premises, and an appointed triage nurse (by consulting an 
on-call physician if deemed necessary) decides to which specialty and level of care the patient is 
referred to first. If the patient presented to an ER with both surgical and internal medicine ER, the 
specialty which patient was referred to first determined whether the patient was classified to SER or 
non-SER group. The hospital, to which the patient is initially transported to, is decided by the 
paramedics (by consulting an on-call prehospital emergency physician if deemed necessary). 
Patients with acute abdomen are instructed to be referred to a SER. Vascular centre refers to 
Helsinki University Hospital, which is where all the patients were finally referred to. 
Timestamps of first ER presentation, CT scan, CT report and arrival to vascular centre were 
extracted from electronic patient records. Time of diagnosis was the first time hospital notes 
mentioned AMI as the working diagnosis. Date of death was obtained from electronic patient 
records, which automatically updates the information from the Population Register Centre thus 
enabling to record mortality for all patients. 
Charlson comorbidity index (CCI) was used to assess comorbidity of patients17. Quick Sepsis 
Related Organ Failure Assessment (qSOFA) was used to evaluate organ dysfunction at the time of 
the arrival at the vascular centre18.  
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Patients  
Patient records were analysed and data regarding patient characteristics, hospital stay, treatment, 
and outcome were manually extracted. Patients with no AMI (incorrect diagnosis code), no 
timestamp available, non-occlusive or venous ischaemia, bowel ischaemia caused by strangulation, 
trauma, or isolated coeliac trunk stenosis as well as ischaemia isolated to colon were excluded. 
Because the study aim was to analyse delays in the treatment of AMI, patients whose symptoms 
started in the hospital during treatment of another disease, who were not eligible for interventional 
treatment because of comorbidity or advanced age, who had a diagnosed chronic mesenteric 
ischaemia as well as patients with subacute onset of mesenteric ischaemia (defined as delay more 
than 48 hours from symptom outset to vascular centre) were excluded, in an effort to limit the study 
group to patients with an acute disease.  
 
Statistics 
All statistical analyses were done using IBM SPSS Statistics version 23 (IBM Corp©, Armonk, 
NY, USA). Mann-Whitney U or Chi-square tests were used in univariate analyses. Multivariate 
analysis was performed using logistic regression. Variables with p < 0.2 in univariate analysis were 
selected for multivariate analysis, except for variables which could be expected to cause 
multicollinearity. The primary endpoint was first-door-to-operation time, which was defined as the 
time from arrival at first ER to the onset of surgery. A two-tailed p-value below 0.05 was 
considered statistically significant. 
 
Results 
Patient characteristics and symptoms 
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A total of 474 patients were identified based on the initial diagnosis and procedural code search. 
After applying exclusion criteria, 81 patients remained for final analysis. Basic characteristics of the 
included patients are shown in Table 1. Briefly, the patients were elderly (median age 78 years) 
with an equal sex distribution. The majority (n=71, (88%) had some form of cardiovascular disease 
and roughly every third patient (n=29, 36%) had diabetes. More than half of the patients (n=46, 
57%) had atrial fibrillation. Two thirds were independent, and 13 (16%) were institutionalised. 
Abdominal pain was the most common symptom (n=79, 98%), followed by vomiting/nausea (n=48, 
59%) (Table 2). CT was performed on 18 (22%) patients in the first ER, and 14 (17%) of the CTs 
were performed with intravenous contrast. CT was performed on 53 (65%) patients at the tertiary 
vascular centre, and overall 69 (85%) patients underwent CT before intervention. The most 
common first working diagnosis was unspecified acute abdomen (n=28, 35%) (Table 2). At the 
presentation at vascular centre, abdominal guarding was present in 35 (43%) patients (Table 2). 
Diagnosis of AMI was made during laparotomy in 10 (12%) patients (Table 2).  
 
Factors related to the delay  
Factors associated with the delay were analysed in univariate analysis (Supplementary Table 1). 
The first-door-to-operation time was significantly shorter if the first medical centre was a surgical 
ER (10.1 hours versus 15.2 hours, p = 0.025), if AMI was correctly diagnosed in the first medical 
centre (median 9.3 hours versus 13.9 hours, p = 0.006), or if SMA occlusion was correctly 
identified in the CT (11.7 hours versus 18.0 hours, p = 0.005) (Supplementary Table 1).  
In multivariate analysis, first medical centre being SER was independently associated with a shorter 
first-door-to-operation delay (Table 3). 
 
Pathway to treatment 
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As the first ER was the strongest predictor of delay, pathways to treatment were examined in more 
detail. Of 81 patients, 51 presented first to non-SER, 14 to SER without vascular on-call and 16 to 
SER with vascular on-call (vascular centre). Of the 51 patients presenting first to non-SER, 8 (16%) 
were referred to SER without vascular on-call, while 43 (84%) patients were referred to SER with 
vascular on-call. Basic patient characteristics were similar regardless of whether patient presented 
to SER or non-SER initially (Table 1). There were no differences regarding aetiology (embolism vs. 
thrombosis), specific symptoms, or duration of symptoms between patients arriving first at SER or 
non-SER (Table 2). CT was more often obtained in the first ER if patient presented first to SER and 
the first working diagnosis was more often mesenteric ischaemia in SER (Table 2). The most 
common incorrect diagnoses in the SER group were ruptured abdominal aneurysm (n=6, 20%) and 
unspecified acute abdomen (n=3, 10%). In the non-SER group, the most common incorrect 
diagnoses were non-specific acute abdomen (n=25, 49%) and gastroenteritis (n=4, 8%) (Table 2). In 
patients with known atheroschlerosis (n=27), AMI was correctly suspected in nine (33%) patients. 
In patients with known atrial fibrillation (n=46), AMI was correctly suspected in 13 (28%) patients. 
(Table 2). 
Upon arrival at the vascular centre, guarding and qSOFA-scores were similar regardless whether 
patients first presented to SER or non-SER (Table 2).  
 
Details of the delays 
The delays were compared in more detail between patients presenting first at SER versus non-SER. 
Door-to-CT, door-to-diagnosis, and door-to-operation times were all shorter in the SER group 
compared to the non-SER group (Table 2).  
 
Primary operative treatment 
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Of the 81 patients, 4 (5%) underwent endovascular therapy only. Of those undergoing laparotomy 
(n = 77), extensive and unsalvageable bowel necrosis was found in 14 (18%) patients and due to 
poor prognosis, these patients underwent explorative laparotomy only. Of the rest of patients, 20 
(26%) underwent bowel resection only, 15 (19%) underwent revascularisation without bowel 
resection and 28 (36%) underwent revascularisation followed by bowel resection (Table 4). The 
abdominal cavity was left open in 9 (12%) patients who were planned to undergo a second look 
laparotomy. Consultation of vascular surgeon was mentioned in thirteen patients’ (65%) records of 
the twenty patients who underwent bowel resection only.  
There were no significant differences in the choice of operative treatment between the SER and 
non-SER groups, including the number of futile explorative laparotomies (Table 4).  
 
Outcomes 
Median follow-up time was 1.3 weeks (IQR 0.2-59.4), much due to the high mortality. Fifty 
patients (62%) died during the first 30 days and 53 (65%) during the first 90 days. While there were 
no significant differences in rate of intensive care unit (ICU) admission or ICU stay, shorter 
hospital stay (median 6.5 days (4.0-10.3) vs. 10.8 days (7.0-22.3), p = 0.045), as well as lower 90-
day mortality (50% vs. 75%) were noted in the SER group compared to the non-SER group (Table 
4). Factors associated with 90-day mortality in univariate analyses and multivariate analysis were 
non-SER as the first ER (OR 3.2), no antithrombotic medication at presentation (OR 4.8), patients’ 
dependency (OR 6.9), and qSOFA > 0 on arrival to the vascular centre (OR 4.7) (Supplemenatry 
Table 2, Table 3). 
 
Discussion 
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In this study, the most important prognostic factor of the patients with AMI was the type of ER the 
patients were examined first. Patients examined first in a surgical ER had shorter first-door-to-
operation times (10 versus 15 hours), shorter hospital stays (7 versus 11 days) and lower 90-day 
mortality rate (50% versus 75%) compared to being examined first in a non-surgical ER. Although 
selected in retrospect the two groups were similar in regards to medical history, clinical 
presentation, final diagnosis (embolic vs thrombotic) and selected treatment, suggesting that there is 
an element of chance that has an effect on the choice of the initial ER and outcome. We should 
therefore target an educational effort to triage-nurses and paramedics in order to minimise the false 
referrals.  
Various studies have stressed the need for more efficient diagnostics and shorter delays in the 
treatment of AMI.3,14,19 Previous studies have shown that clinical suspicion and CT imagining are 
crucial components of delay.14-16 The study of Lehtimäki et al. also found that radiological detection 
of AMI in CT is improved if the clinician suspects the diagnosis.16 In our study, we found both 
clinical suspicion and CT imagining to be related to the status of the first medical centre. It is 
widely recommended that patients with a suspicion of AMI should be imaged with adequately 
timed CT angiography.3,4,20 Our material was too small to detect a difference between contrast 
enhanced and native CT.  
Our mortality rates (51% in SER group and 72% in non-SER group) did not differ significantly 
from previously published mortality figures of 42-69%.11,21-24 Lower rates of mortality for AMI 
have been presented25 but the mortality figures are significantly influenced by a selection bias, 
when only revascularized patients are reported. In order to focus specifically on AMI and avoid 
cases with subacute onset, we excluded the patients with a prolonged referral (more than 48h) and 
in-hospital initiated symptoms, a decision that led to a smaller, but more homogenous patient group 
with acute and severe AMI. Also our material includes specifically only arterial AMI, whereas 
patients with venous mesenteric ischaemia were excluded as they have more favourable prognosis 
and different delay pattern.26-29  
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Some studies have shown mortality to increase with the lengthening of first-door-to-operation 
time.15,30,31 We did not detect this in our material (Supplementary Table 2), which we believe to be 
due to the inevitable remainder of heterogeneity of our patient sample despite efforts to homogenize 
the cohort. Another reason might be the fact that patients with more serious symptoms travel 
through the system faster. These patients are usually the ones with a more severe disease and hence 
have a higher mortality. The patients with less severe disease often have less serious symptoms thus 
it may take more time to proceed to operation. These patients might be able to tolerate longer 
delays, possibly due to the extent and anatomy of the obstruction (partial vs total, proximal vs more 
distal), among other things. We believe this disparity of patients to be a possible explanation to the 
lack of correlation between delay and outcome. As a matter of fact, another report from Sweden did 
not find correlation between survival and delay from onset of symptoms to operation.11  We made 
an effort to further subgroup the occlusions in regards to number of side branches prior to the 
occlusion, length of occlusion etc, but the number of contrast enhanced CT:s remained too small to 
make any conclusions. In order to be able to achieve fast track diagnosis and revascularisation, 
these patients need to be identified from a large cohort with more or less unspecific symptoms. A 
high level of suspicion and a low threshold for contrast enhanced CT imaging should be practiced.20 
The fear of acute kidney injury should not prevent proper diagnostics for this deadly disease, 
especially as the nephrotoxicity of contrast media has been questioned.32 Once the diagnosis is 
suspected and confirmed, immediate treatment should be undertaken. The vascular surgeons choose 
the method of revascularisation and should be capable of performing all forms of interventions 
either by themselves or together with endovascular operators. There is suggestive information in the 
literature that endovascular treatment should be favoured, but all comparative studies suffer from 
selection bias.4,33 Therefore, the level of evidence is low, and the choice of treatment must 
ultimately be made on an individual basis. 
Antithrombotic medication at presentation and patients with a good functional status had a better 
outcome, while qSOFA > 0 was associated with a higher mortality (Table 4). Because this is a 
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retrospective analysis we are not able to show a clear causation, but we hypothesise that 
antithrombotic medication might inhibit progression of the thrombotic cascade and thus limit the 
severity of the event. 
A good functional status predicted a better outcome, which might be due to less comorbidity and 
hence lower risks of organ failure. It might also be that more aggressive treatment was pursued in 
this patient group. 
qSOFA is used as a bedside estimate to identify patients with suspected infection that would benefit 
from ICU treatment. It consists of an evaluation of Glascow Coma Scale, respiratory rate and 
systolic blood pressure. Deterioration of these values can, in addition to infection, be a sign of more 
extensive disturbance of vital functions and bowel ischaemia, which would explain why a higher 
qSOFA was associated with a higher mortality. 
This study has several limitations. As a retrospective study there is an inherent risk of information 
bias and misclassifications. By identifying and excluding clearly different patient groups we made 
an effort to make the material more homogenous and focus on acute and severe AMI. Despite this, 
the pattern of the disease remains variable and limits the conclusions that can be drawn from the 
material. Focusing on arterial AMI made the study groups smaller and poses challenges on the 
statistical analysis. On the other hand, the strength of this paper is the population-based study 
design that diminishes selection bias. 
In order to improve the outcomes of AMI, the first-door-to-operation times need to be shortened. 
One of our main findings was that these patients fare better if they present directly to units with 
surgical expertise. The awareness of paramedical units and ER personnel performing triage should 
be improved. The referral patterns need to be improved and all suspected AMI patients should find 
their way without delay to a unit performing revascularisations, either dedicated intestine stroke 
centres or as in our situation centralised on-call units with possibilities for multidisciplinary 
treatment at all times.12,13 Our results highlight the fact that these units should also take a role in the 
 11 
education and design of the whole treatment chain starting from first responders. Future studies 
should try to identify simple clinical combinations of symptoms that could guide the triage and 
improve outcome of AMI patients. 
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Table 1. Basic demographics based on first emergency room (surgical or non-surgical). 
 All 
 
n=81 
n (%) 
Surgical  
ER 
n = 30 
n (%) 
Non-
surgical 
ER 
n = 51 
n (%) 
p 
Age, years, median (IQR) 78.0 (69.0-
85.0) 
81.0 (65.3-
84.0) 
77.0 (70.0-
85.0) 
0.512 
Sex, female 39 (48.1%) 15 (50.0%) 24 (47.1%) 0.798 
Comorbidities 
Hypertension 
Atrial fibrillation 
Atherosclerosis 
Coronary artery disease 
Cerebrovascular disease (stroke / TIA) 
History of thromboembolism 
Diabetes 
with complications 
without complications 
No cardiovascular diseases 
Charlson comorbidity index 
0 
1-2 
3-4 
 > 4 
 
50 (61.7%) 
46 (56.8%) 
27 (33.3%) 
33 (40.7%) 
15 (18.5%) 
5 (6.2%) 
 
4 (4.9%) 
25 (30.9%) 
10 (12.3%) 
 
1 (1.2%) 
19 (23.5%) 
25 (30.8%) 
36 (44.4%) 
 
 
16 (53.5%) 
16 (53.5%) 
9 (30.0%) 
12 (40.0%) 
4 (13.3%) 
2 (6.7%) 
 
1 (3.3%) 
9 (30.0%) 
2 (6.7%) 
 
0 (0%) 
7 (23.4%) 
10 (33.4%) 
13 (43.3%) 
 
34 (66.7%) 
30 (58.8%) 
18 (35.3%) 
21 (41.2%) 
11 (21.5%) 
3 (5.9%) 
 
3 (5.9%) 
16 (31.4%) 
8 (15.7%) 
 
1 (2.0%) 
12 (23.6%) 
15 (29.4%) 
23 (45.1%) 
 
0.233 
0.630 
0.625 
0.917 
0.631 
0.887 
0.858 
 
 
0.233 
0.996 
 
ASA 
1-2 
3-4 
5 
 
1 (1.2%) 
49 (60.5%) 
27 (33.3%) 
 
0 (0%) 
17 (56.7%) 
11 (36.7%) 
 
1 (2.0%) 
32 (62.8%) 
16 (31.4%) 
0.601 
Medication  
Anticoagulation*  
Antithrombotic#  
Statin 
 
20 (24.7%) 
43 (53.1%) 
33 (40.7%) 
 
5 (16.7%) 
18 (60.0%) 
11 (36.7%) 
 
15 (29.4%) 
25 (49.0%) 
22 (43.1%) 
 
0.145 
0.431 
0.602 
Functional status 
Independent 
Partially dependent 
Institutionalized 
 
57 (70.4%) 
11 (13.6%) 
13 (16.0%) 
 
21 (70.0%) 
3 (10.0%) 
6 (20.0%) 
 
36 (70.6%) 
8 (15.7%) 
7 (13.7%) 
0.633 
 15 
Abbreviations: ER – emergency room, IQR – interquartile range, TIA – transient ischemic attack, 
ASA – American Society of Anaesthesiologists physical status classification. *warfarin, direct oral 
anticoagulant, low molecular weight heparin; #acetylsalicylic acid, dipyridamol, or clopidogrel 
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Table 2. Symptoms, imaging, clinical presentation and delays based on first emergency room 
(surgical or non-surgical). 
 All 
 
n = 81 
n (%) 
Surgical ER 
 
n=30 
n (%) 
Non-surgical ER 
 
n=51 
n (%) 
p 
Symptoms 
Abdominal pain 
Diarrhoea 
Haematochezia 
Vomiting / nausea 
Duration > 24h 
 
79 (97.5%) 
36 (44.4%) 
15 (18.5%) 
48 (59.3%) 
19 (23.5%) 
 
30 (100.0%) 
13 (43.4%) 
5 (16.7%) 
16 (53.3%) 
9 (30.0%) 
 
49 (96.1%) 
23 (45.1%) 
10 (19.6%) 
32 (62.7%) 
10 (19.6%) 
 
0.272 
0.877 
0.742 
0.405 
0.441 
Imaging (in first ER) 
No imaging 
Abdominal plain x-ray 
Computed tomography (any) 
with contrast 
without contrast 
 
37 (45.7%) 
14 (17.3%) 
18 (22.2%) 
14 (17.3%) 
4 (4.9%) 
 
3 (10.0%) 
3 (10.0%) 
13 (43.3%) 
10 (33.3%) 
3 (10.0%) 
 
34 (66.7%) 
11 (21.6%) 
5 (9.8%) 
4 (7.8%) 
1 (2.0%) 
 
<0.001 
0.184 
0.001 
0.003 
0.107 
First working diagnosis 
AMI 
Acute abdomen, not specified 
Intra-abdominal infection 
Ileus 
Gastrointestinal bleeding 
Gastroenteritis / colitis 
Ruptured aortic aneurysm 
Acute coronary syndrome 
Decreased general condition 
Other* 
 
23 (28.4%) 
28 (34.6%) 
5 (6.2%) 
4 (4.9%) 
3 (3.7%) 
5 (6.2%) 
6 (7.4%) 
2 (2.5%) 
2 (2.5%) 
3 (3.7%) 
 
15 (50.0%) 
3 (10.0%) 
2 (6.7%) 
1 (3.3%) 
0 (0%) 
1 (3.3%) 
6 (20.0%) 
1 (3.3%) 
0 (0%) 
1 (3.3%) 
 
8 (15.7%) 
25 (49.0%) 
3 (5.9%) 
3 (5.9%) 
3 (5.9%) 
4 (7.9%) 
0 (0%) 
1 (2.0%) 
2 (3.9%) 
2 (3.9%) 
<0.001 
 
 
 
 
 
Correct working diagnosis in patients with 
atherosclerosis, n=27 
9 (33.3%) 6 (66.7%), n=9 3 (16.7%), n=18 0.051 
Correct working diagnosis in patients with 
atrial fibrillation, n=46 
13 (28.3%) 7 (43.8%), n=16 6 (20.0%), n=30 0.171 
Clinical presentation at vascular centre 
Guarding 
qSOFA 
0 
1 
2 
3 
CRP, mg/L (median, IQR) 
Creatinine, mol/L (median, IQR) 
 
35 (43.2%) 
 
28 (34.6%) 
37 (45.7%) 
13 (16.0%) 
3 (3.7%) 
73 (18-193) 
103 (65-137) 
 
9 (30.0%) 
 
12 (40.0%) 
14 (46.7%) 
4 (13.3%) 
0 (0%) 
93 (11-195) 
95 (66-153) 
 
26 (51.0%) 
 
16 (31.4%) 
23 (45.1%) 
9 (17.6%) 
3 (5.9%) 
71 (18-163) 
105 (64-135) 
 
0.066 
0.494 
 
 
 
 
0.825 
1.000 
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Lactate, mmol/L (median, IQR) 2.9 (1.9-5.2) 2.5 (1.8-4.5) 3.1 (1.9-7.5) 0.219 
Imaging at vascular centre 
                       Computed tomography (any) 
                                            with contrast 
                                            without contrast 
 
53 (65.4%) 
32 (39.5%) 
21 (25.9%) 
 
17 (56.7%) 
5 (16.7%) 
12 (14.8%) 
 
36 (70.6%) 
20 (39.2%) 
16 (31.4%) 
 
0.203 
0.944 
0.145 
Mesenteric ischaemia diagnosis made in 
laparotomy 
10 (12.3%) 3 (10.0%) 7 (13.7%) 0.623 
Aetiology 
Embolism 
Thrombosis 
 
41 (50.6%) 
40 (49.4%) 
 
18 (60.0%) 
12 (40.0%) 
 
23 (45.1%) 
28 (54.9%) 
0.195 
Delay, hours, median (IQR) 
Door-to-CT (n=79) 
Door-to-surgical ER (n=51) 
Door-to-diagnosis (n=77) 
CT-to-operation (n=79) 
Door-to-operation (n=81) 
 
 
5.5 (2.7-10.6) 
n/a 
6.5 (2.8-12.9) 
5.5 (3.4-9.0) 
12.6 (9.2-19.7) 
 
2.7 (1.8-4.9) 
n/a 
3.1 (0.8-6.8) 
6.0 (3.6-16.5) 
10.1 (6.9-18.5) 
 
8.4 (4.3-12.1) 
3.5 (2.4-7.1) 
10.0 (5.1-15.9) 
5.3 (3.4-8.8) 
15.2 (10.9-21.2) 
 
<0.001 
n/a 
<0.001 
0.275 
0.025 
Abbreviations: AMI – acute mesenteric ischaemia, CRP – C-reactive protein, IQR – interquartile 
range, qSOFA – quick sepsis related organ failure assessment. *(intra-abdominal infection, 
perforation) 
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Table 3. Multivariate analysis on parameters affecting first-door-to-operation delay and 90-day 
mortality. 
 
 
First-door-to-operation 
delay > 12h 
 
OR (95% confidence 
interval) 
90-day mortality 
 
OR (95% confidence 
interval) 
First ER 
Surgical 
Non-surgical 
 
reference 
3.7 (1.3-10.2) 
 
reference 
3.2 (1.03 - 9.6) 
No antithrombotic 
medication at presentation 
 4.8 (1.45 – 15.9) 
Dependent  6.9 (1.63 – 29.1) 
qSOFA > 0 on arrival to 
vascular centre 
 4.7 (1.5 - 14.3) 
Abbreviations: ER – emergency room, OR – odds ratio, qSOFA – quick sepsis related organ 
failure assessment. 
Parameters in Suppmentary Table 1 with p < 0.2 were selected for multivariate logistic 
regression for door-to-operation delay > 12h, except for variable “mesenteric ischaemia 
suspected before CT” to avoid collinearity.  
Parameters in Supplementary Table 2 with p < 0.2 were selected for multivariate logistic 
regression for 90-day mortality, except for variable “mesenteric ischaemia suspected before 
CT” to avoid collinearity.  
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Table 4. Primary intervention and outcomes, based on whether first ER was surgical or not. 
 All  
 
n=81 
n (%) 
Surgical ER  
 
n = 30 
n (%) 
Non-surgical 
ER  
n = 51 
n (%) 
p 
Primary intervention 
Endovascular treatment only 
Laparotomy, only 
exploration  
Laparotomy, only bowel 
resection 
Laparotomy, only vascular 
procedure 
Embolectomy 
Bypass 
Endarterectomy 
Endovascular 
therapy 
Laparotomy, bowel resection 
and vascular procedure 
Embolectomy 
Bypass 
Endarterectomy 
Endovascular 
therapy# 
 
4 (4.9%) 
14 (17.3%) 
 
20 (24.7%) 
15 (18.5%) 
 
13 (16.0%) 
2 (2.5%) 
0 (0%) 
0 (0%) 
 
28 (34.6%) 
14 (17.3%) 
10 (12.3%) 
1 (1.2%) 
3 (3.7%) 
 
2 (6.7%) 
3 (10.0%) 
 
4 (13.3%) 
7 (23.3%) 
 
5 (16.7%) 
2 (6.7%) 
0 (0%) 
0 (0%) 
 
14 (46.7%) 
6 (20.0%) 
4 (13.3%) 
1 (3.3%) 
3 (10.0%) 
 
2 (3.9%) 
11 (21.6%) 
 
16 (31.4%) 
8 (15.7%) 
 
8 (15.7%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
14 (27.5%) 
8 (15.7%) 
6 (11.8%) 
0 (0%) 
0 (0%) 
 
0.582 
0.184 
 
0.069 
0.392 
 
 
 
 
 
0.079 
Irreversible bowel ischaemia 62 (76.5%) 21 (70.0%) 41 (80.4%) 0.286 
Open abdomen 9 (11.1%) 6 (20.0%) 3 (5.9%) 0.149 
ICU admission 29 (35.8%) 10 (33.3%) 19 (37.3%) 0.722 
ICU-free days*, median (IQR) 5 (1-24) 12 (1-26) 4 (0-24) 0.189 
Length of ICU admission within 28 days, 
days, median (IQR)   
5.0 (2.8-7.3) 5.0 (3.8-6.3) 4.0 (2.0-8.0) 0.363 
Length of hospital stay, days, median 
(IQR) 
8.8 (5.9-15.5) 6.5 (4.0-10.3) 10.8 (7.0-22.3) 0.045 
30-day mortality 50 (61.7%) 15 (50.0%) 35 (68.6%) 0.096 
90-day mortality 53 (65.4%) 15 (50.0%) 38 (74.5%) 0.025 
Abbreviations: ASA – American Society of Anaesthesiologists physical status classification, ICU – 
intensive care unit, IQR – interquartile range. *Days in which patient was not in ICU and alive 
within 28 days from intervention #endovascular therapy was performed via groin puncture prior 
laparotomy 
Supplementary Table 1. Univarite analysis on parameters affecting door-to-operation delay. 
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 Door-to-operation 
delay (h), median 
(IQR) 
Door-to-operation 
delay (h), median 
(IQR) 
P value 
Sex (female/male) 16.2 (10.2-21.2) 
n=39 
11.4 (8.7-17.6) 
n=42 
0.255 
Age (<65/>65) 9.9 (6.8-15.9) 
n=15 
13.6 (9.5-21.0) 
n=66 
0.102 
Cardiovascular disease (yes/no) 12.0 (9.1-19.4) 
n=71 
16.6 (10.9-24.0) 
n=10 
0.389 
Diabetes (yes/no) 12.8 (9.2-19.7) 
n=29 
12.6 (8.1-20.7) 
n=52 
0.972 
Atrial fibrillation (yes/no) 11.6 (7.2-19.7) 
n=46 
15.2 (10.2-20.0) 
n=35 
0.275 
Previous thromboembolism (yes/no) 12.6 (8.5-25.3) 
n=5 
12.7 (9.2-19.9) 
n=76 
0.992 
Independent (yes/no) 13.9 (8.4-24.7) 
n=57 
11.8 (9.9-17.1) 
n=24 
0.203 
qSOFA (0/other) 11.2 (7.3-20.6) 
n=28 
13.9 (9.6-19.6) 
n=53 
0.427 
Defance (yes/no) 12.0 (9.3-20.0) 
n=35 
13.0 (7.6-19.8) 
n=46 
0.901 
CRP (>100/<100) 12.6 (9.2-22.2) 
n=32 
13.6 (9.6-19.2) 
n=46 
0.835 
First ER (SER/non-SER) 10.1 (6.9-18.5) 
n=30 
15.2 (10.9-21.2) 
n=51 
0.025 
First working diagnosis mesenteric 
ischaemia (yes/no) 
9.3 (6.2-18.2) 
n=23 
13.9 (10.5-21.5) 
n=58 
0.006 
Mesenteric ischaemia suspected before CT 
(yes/no) 
10.4 (6.2-19.4) 
n=19 
14.5 (10.0-21.1) 
n=56 
0.055 
CT (yes/no) 12.7 (9.5-20.3) 
n=74 
9.1 (5.8-19.2) 
n=7 
0.282 
CT with contrast (yes/no) 12.8 (7.6-20.0) 
n=47 
12.4 (9.6-19.7) 
n=34 
0.920 
CT in first ER (yes/no) 10.5 (7.2-18.3) 
n=24 
14.0 (9.6-21.1) 
n=57 
0.104 
Mesenteric ischaemia identified on CT 
(yes/no) 
11.7 (7.5-18.5) 
n=54 
18.0 (11.9-27.6) 
n=21 
0.005 
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Distance to vascular centre (under 
10km/over 10km) 
12.6 (7.4-18.9) 
n=45 
12.6 (9.6-20.8) 
n=36 
0.652 
Aetiology (thrombosis/embolism) 12.8 (10.1-19.2) 
n=40 
11.6 (7.0-21.9) 
n=41 
0.427 
 
 
 
 
  
 22 
Supplementary Table 2. Univariate analysis on parameters affecting 90-day mortality. 
 90-day 
mortality, n(%) 
90-day mortality, 
n(%) 
Univariate p-value 
Sex (female/male) 29 (74.4%), 
n=39 
24 (57.1%), 
n=42 
0.104 
Age (<65/>65) 7 (46.7%), 
n=15 
46 (69.7%), 
n=66 
0.090 
Atherosclerosis (yes/no) 18 (66.7%), 
n=27 
35 (64.8%), 
n=54 
0.869 
Diabetes (yes/no) 19 (65.5%), 
n=29 
34 (65.4%), 
n=52 
0.990 
Atrial fibrillation (yes/no) 32 (69.6%), 
n=46 
21 (60.0%), 
n=35 
0.370 
Previous thromboembolism (yes/no) 2 (40.0%), 
n=5 
51 (67.1%), 
n=76 
0.217 
Anticoagulation (yes/no) 14 (66.7%), 
n=21 
39 (65.0%), 
n=60 
0.890 
Antithrombotic medication (yes/no) 24 (54.5%), 
n=44 
29 (78.4%), 
n=37 
0.025 
Independency (independent/no) 33 (57.9%), 
n=57 
20 (83.3%), 
n=24 
0.028 
qSOFA (0/other) 12 (42.9%), 
n=28 
41 (77.4%), 
n=53 
0.002 
Defance (yes/no) 22 (62.9%), 
n=35 
31 (67.4%), 
n=46 
0.671 
First ER (SER/non-SER) 15 (50.0%), 
n=30 
38 (74.5%), 
n=51 
0.025 
First working diagnosis mesenteric 
ischaemia (yes/no) 
15 (65.2%), 
n=23 
38 (65.5%), 
n=58 
0.980 
Mesenteric ischaemia suspected before 
CT (yes/no) 
14 (73.7%), 
n=19 
35 (62.5%), 
n=56 
0.376 
CT in first ER (yes/no) 
 
15 (62.5%), 
n=24 
38 (66.7%), 
n=57 
0.719 
CT (yes/no) 48 (64.9%), 
n=74 
5 (71.4%),  
n=7 
0.727 
CT with contrast (yes/no) 28 (59.6%), 25 (73.5%), 0.192 
 23 
n=47 n=34 
Mesenteric ischaemia identified on CT 
(yes/no) 
33 (61.1%), 
n=54 
16 (76.2%), 
n=21 
0.218 
Distance to vascular centre (under 
10km/over 10km) 
29 (64.4%) 
n=45 
24 (66.7%) 
n=36 
0.834 
Aetiology (thrombosis/embolism)   26 (65.0%), 
n=40 
27 (65.9%), 
n=41 
0.936 
Delay (under 12h/over 12h) 24 (64.9%), 
n=37 
29 (65.9%), 
n=44 
0.922 
Abbreviations: CT – computed tomography, OR – odds ratio, SER – surgical emergency room, 
non-SER – non-surgical emergency room. 
 
 
 
 
 
 
 
 
 
 
